You are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry.
Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Enter a Company name above to access free BCIQ profiles. Request a trial to unlock the full value of BCIQ.
Foundation for Prader-Willi Research
Headquarters:Walnut, CA
Year Founded:N/A
Status:Non-Profit or Major Disease Foundation
Biopharma related deals can be found by searching the organization's name in the BCIQ Deals Module*.*desktop version only

BioCentury | Mar 04, 2020

Finance

March 3 Quick Takes: Megarounds for Akouos, Element; plus venture rounds by Kahr, Primmune, Lipidio and Scipio and more

Pivotal bioVentures, crossovers back Akouos in $105M series B Akouos Inc., a gene therapy company developing treatments for hearing loss, raised $105 million in a series B round led by Pivotal bioVentures. New investors included...

BioCentury | Apr 07, 2017

Strategy

Pushing for progress in Prader-Willi

...clinical failure of Zafgen Inc. ’s subcutaneous beloranib for obesity in Prader-Willi syndrome patients, the Foundation for Prader-Willi Research...
...Marseille, France Cardiff University, Cardiff, U.K. Cystic Fibrosis Foundation, Bethesda, Md. Duke University, Durham, N.C. Foundation for Prader-Willi Research...
...a mouse model of Prader-Willi syndrome.” Nature Medicine (2016) Mark Zipkin, Staff Writer Aix-Marseille University Cardiff University Cystic Fibrosis Foundation Foundation for Prader-Willi Research Italian...

BioCentury | Dec 14, 2015

Product Development

Risk-benefit litmus test

...of Prader-Willi, according to the company. However, Theresa Strong, chair of the SAB of the Foundation for Prader-Willi Research...
...Mass. Bronson Methodist Hospital, Kalamazoo, Mich. Chong Kun Dang Pharmaceutical Corp. (KSE:001630), Seoul, South Korea Foundation for Prader-Willi Research...